Cargando…

Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012

PURPOSE: For several years the Working Group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine has been performing a regular survey to obtain information on technique, utilization and development of myocardial perfusion scintigraphy (MPS). Currently, data of six surveys from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindner, O., Bengel, F. M., Hacker, M., Schäfer, W., Burchert, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978223/
https://www.ncbi.nlm.nih.gov/pubmed/24519554
http://dx.doi.org/10.1007/s00259-013-2683-5
_version_ 1782310527138004992
author Lindner, O.
Bengel, F. M.
Hacker, M.
Schäfer, W.
Burchert, W.
author_facet Lindner, O.
Bengel, F. M.
Hacker, M.
Schäfer, W.
Burchert, W.
author_sort Lindner, O.
collection PubMed
description PURPOSE: For several years the Working Group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine has been performing a regular survey to obtain information on technique, utilization and development of myocardial perfusion scintigraphy (MPS). Currently, data of six surveys from 2005 to 2012 are available. The aim of this paper is to deliver a general and comprehensive overview of all surveys documenting the course of patient doses over time and the development of the method. METHODS: A one-page questionnaire with number of MPS patients, number of stress and rest MPS, referral structure and several technical issues was sent to all centres performing MPS in Germany and evaluated. With the data on protocol utilization, effective MPS patient doses were estimated. RESULTS: MPS per million population (pmp) varied between 2,380 and 2,770. In 2012, MPS pmp showed a slight increase for the first time. From 2005 to 2009 the angiography to MPS ratio increased from 3.4 to 4.4, and the revascularization to MPS ratio decreased from 0.66 to 0.53. In 2012, both indices demonstrated an opposite trend for the first time (4.1 and 0.55). A total of 108 centres participated in all surveys. They showed an increase in MPS patients of 4.0 % over the reporting period. In 2012, more than 50 % of the centres experienced no change or an increase in MPS numbers. The leading single competitor was MRI, followed by angiography and stress echocardiography. (201)Tl studies have decreased since 2005 from 20 to 5 %. (99m)Tc MPS studies showed a mild increase in 2-day protocols. In 2012, the average effective dose per patient was estimated at 7.4 mSv. Due to the decreasing use of (201)Tl, a mild decline over the observation period can be documented. Dynamic exercise stress was the most common stress test and adenosine the leading pharmacological stress agent, with a growing percentage. In 2012, the regadenoson percentage was 9 %. Gated single photon emission computed tomography (SPECT) noted an increasing acceptance with >70 % in 2012. The segmental scoring of perfusion studies had a low acceptance. Ambulatory care cardiologists represented the major referral group. CONCLUSION: Germany has a moderate to moderate-high MPS utilization rate. Nevertheless, coronary artery disease (CAD) diagnosis and disease management are dominated by angiography. The survey data reveal a positive trend in MPS and a decrease in average patient dose reflecting good practice with guideline adherence, the implementation of technical improvements and success in training.
format Online
Article
Text
id pubmed-3978223
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-39782232014-04-22 Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012 Lindner, O. Bengel, F. M. Hacker, M. Schäfer, W. Burchert, W. Eur J Nucl Med Mol Imaging Original Article PURPOSE: For several years the Working Group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine has been performing a regular survey to obtain information on technique, utilization and development of myocardial perfusion scintigraphy (MPS). Currently, data of six surveys from 2005 to 2012 are available. The aim of this paper is to deliver a general and comprehensive overview of all surveys documenting the course of patient doses over time and the development of the method. METHODS: A one-page questionnaire with number of MPS patients, number of stress and rest MPS, referral structure and several technical issues was sent to all centres performing MPS in Germany and evaluated. With the data on protocol utilization, effective MPS patient doses were estimated. RESULTS: MPS per million population (pmp) varied between 2,380 and 2,770. In 2012, MPS pmp showed a slight increase for the first time. From 2005 to 2009 the angiography to MPS ratio increased from 3.4 to 4.4, and the revascularization to MPS ratio decreased from 0.66 to 0.53. In 2012, both indices demonstrated an opposite trend for the first time (4.1 and 0.55). A total of 108 centres participated in all surveys. They showed an increase in MPS patients of 4.0 % over the reporting period. In 2012, more than 50 % of the centres experienced no change or an increase in MPS numbers. The leading single competitor was MRI, followed by angiography and stress echocardiography. (201)Tl studies have decreased since 2005 from 20 to 5 %. (99m)Tc MPS studies showed a mild increase in 2-day protocols. In 2012, the average effective dose per patient was estimated at 7.4 mSv. Due to the decreasing use of (201)Tl, a mild decline over the observation period can be documented. Dynamic exercise stress was the most common stress test and adenosine the leading pharmacological stress agent, with a growing percentage. In 2012, the regadenoson percentage was 9 %. Gated single photon emission computed tomography (SPECT) noted an increasing acceptance with >70 % in 2012. The segmental scoring of perfusion studies had a low acceptance. Ambulatory care cardiologists represented the major referral group. CONCLUSION: Germany has a moderate to moderate-high MPS utilization rate. Nevertheless, coronary artery disease (CAD) diagnosis and disease management are dominated by angiography. The survey data reveal a positive trend in MPS and a decrease in average patient dose reflecting good practice with guideline adherence, the implementation of technical improvements and success in training. Springer Berlin Heidelberg 2014-02-12 2014 /pmc/articles/PMC3978223/ /pubmed/24519554 http://dx.doi.org/10.1007/s00259-013-2683-5 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Lindner, O.
Bengel, F. M.
Hacker, M.
Schäfer, W.
Burchert, W.
Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title_full Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title_fullStr Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title_full_unstemmed Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title_short Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012
title_sort use of myocardial perfusion imaging and estimation of associated radiation doses in germany from 2005 to 2012
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978223/
https://www.ncbi.nlm.nih.gov/pubmed/24519554
http://dx.doi.org/10.1007/s00259-013-2683-5
work_keys_str_mv AT lindnero useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012
AT bengelfm useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012
AT hackerm useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012
AT schaferw useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012
AT burchertw useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012
AT useofmyocardialperfusionimagingandestimationofassociatedradiationdosesingermanyfrom2005to2012